163 related articles for article (PubMed ID: 8384036)
21. Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector.
Johnson PA; Yoshida K; Gage FH; Friedmann T
Brain Res Mol Brain Res; 1992 Jan; 12(1-3):95-102. PubMed ID: 1312210
[TBL] [Abstract][Full Text] [Related]
22. Targeted gene transfer to nigrostriatal neurons in the rat brain by helper virus-free HSV-1 vector particles that contain either a chimeric HSV-1 glycoprotein C-GDNF or a gC-BDNF protein.
Wang X; Kong L; Zhang GR; Sun M; Geller AI
Brain Res Mol Brain Res; 2005 Sep; 139(1):88-102. PubMed ID: 15993510
[TBL] [Abstract][Full Text] [Related]
23. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
[TBL] [Abstract][Full Text] [Related]
24. Long-term expression of genes in vivo using non-replicating HSV vectors.
Bloom DC; Lokensgard JR; Maidment NT; Feldman LT; Stevens JG
Gene Ther; 1994; 1 Suppl 1():S36-8. PubMed ID: 8542391
[No Abstract] [Full Text] [Related]
25. Gene transfer with herpes simplex vectors.
Lachmann RH; Efstathiou S
Curr Opin Mol Ther; 1999 Oct; 1(5):622-32. PubMed ID: 11249669
[TBL] [Abstract][Full Text] [Related]
26. Replication-defective recombinant herpes simplex virus vectors.
Johnson PA; Friedmann T
Methods Cell Biol; 1994; 43 Pt A():211-30. PubMed ID: 7823863
[No Abstract] [Full Text] [Related]
27. [Latency of herpes simplex virus. Current knowledge].
Catalán V; Gimeno C; García-de-Lomas J
Enferm Infecc Microbiol Clin; 1991 Mar; 9(3):172-6. PubMed ID: 1650583
[No Abstract] [Full Text] [Related]
28. Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system.
Palmer JA; Branston RH; Lilley CE; Robinson MJ; Groutsi F; Smith J; Latchman DS; Coffin RS
J Virol; 2000 Jun; 74(12):5604-18. PubMed ID: 10823868
[TBL] [Abstract][Full Text] [Related]
29. Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors.
Schmeisser F; Donohue M; Weir JP
Hum Gene Ther; 2002 Dec; 13(18):2113-24. PubMed ID: 12542843
[TBL] [Abstract][Full Text] [Related]
30. Enhanced reporter gene expression in the rat brain from helper virus-free HSV-1 vectors packaged in the presence of specific mutated HSV-1 proteins that affect the virion.
Yang T; Zhang GR; Zhang W; Sun M; Wang X; Geller AI
Brain Res Mol Brain Res; 2001 May; 90(1):1-16. PubMed ID: 11376851
[TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus-based vectors.
Lachmann R
Int J Exp Pathol; 2004 Oct; 85(4):177-90. PubMed ID: 15312123
[TBL] [Abstract][Full Text] [Related]
32. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus.
Brubaker JO; Thompson CM; Morrison LA; Knipe DM; Siber GR; Finberg RW
J Immunol; 1996 Aug; 157(4):1598-604. PubMed ID: 8759744
[TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus type 1 vector mediated gene transfer to muscle.
Huard J; Goins WF; Glorioso JC
Gene Ther; 1995 Aug; 2(6):385-92. PubMed ID: 7584113
[TBL] [Abstract][Full Text] [Related]
34. Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy.
Freese A; Geller A
Nucleic Acids Res; 1991 Dec; 19(25):7219-23. PubMed ID: 1662813
[TBL] [Abstract][Full Text] [Related]
35. Defective viral vectors as agents for gene transfer in the nervous system.
Kaplitt MG; Makimura H
J Neurosci Methods; 1997 Jan; 71(1):125-32. PubMed ID: 9125381
[TBL] [Abstract][Full Text] [Related]
36. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
[TBL] [Abstract][Full Text] [Related]
37. The history of the HSV amplicon: from naturally occurring defective genomes to engineered amplicon vectors.
Frenkel N
Curr Gene Ther; 2006 Jun; 6(3):277-301. PubMed ID: 16787181
[TBL] [Abstract][Full Text] [Related]
38. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.
Geller AI; Yu L; Wang Y; Fraefel C
Exp Neurol; 1997 Mar; 144(1):98-102. PubMed ID: 9126158
[TBL] [Abstract][Full Text] [Related]
39. Nerve growth factor deprivation results in the reactivation of latent herpes simplex virus in vitro.
Wilcox CL; Johnson EM
J Virol; 1987 Jul; 61(7):2311-5. PubMed ID: 3035230
[TBL] [Abstract][Full Text] [Related]
40. High-brightness anterograde transneuronal HSV1 H129 tracer modified using a Trojan horse-like strategy.
Su P; Ying M; Han Z; Xia J; Jin S; Li Y; Wang H; Xu F
Mol Brain; 2020 Jan; 13(1):5. PubMed ID: 31931837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
